❌

Reading view

↗️

Antibody–bottlebrush prodrug conjugates for targeted cancer therapy

βœ‡Nature Biotechnology - Issue - nature.com science feeds
By: Bin Liu Β· Hung V.-T. Nguyen Β· Yivan Jiang Β· Aiden X. Wang Β· Valerie Lensch Β· Zehao Sun Β· Zane H. Boyer Β· Philip A. Raftopoulos Β· Yutong Dai Β· Piper L. MacNicol Β· Yuyan Wang Β· Nidhi Jyotsana Β· Wencong Wang Β· Sachin Bhagchandani Β· Sanjana Hemdev Β· Peyton Shieh Β· Samantha L. Kristufek Β· Magalie Boucher Β· Michael Downes Β· Ronald M. Evans Β· David W. C. MacMillan Β· Jeremiah A. Johnson

Nature Biotechnology, Published online: 09 September 2025; doi:10.1038/s41587-025-02772-z

Antibody–bottlebrush conjugates expand the options for drug cargos compared to antibody–drug conjugates.
  •  
  • ↗️
There are no more articles
❌